Poveshchenko A F, Kabakov A V, Bodrova N R, Kapustina V I, Kazakov O V, Koldysheva E V, Cherkas V N, Afonyushkin V N
Research Institute of Clinical and Experimental Lymphology - Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.
Institute of Molecular Pathology and Pathomorphology, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia.
Bull Exp Biol Med. 2024 Dec;178(2):223-226. doi: 10.1007/s10517-025-06311-3. Epub 2025 Jan 7.
We conducted a comparative study of the mammary gland microbiota in female Wistar rats and the microbiota associated with breast cancer (BC) induced by the administration of N-methyl-N-nitrosourea, after surgical treatment, photodynamic therapy (PDT), and chemotherapy (CT). Selective nutrient media and a smear-fingerprint technique were used to study the microbiota. Staphylococcus, Streptococcus, and Lactobacillus were found in the mammary glands of intact rats. The mean number of Staphylococcus CFU increased statistically significantly in all groups of rats with induced BC, compared to intact animals: by 8 times in the BC without treatment group, by 15% in BC+surgery, by 10 times in BC+PDT, by 4 times in BC+PDT+CT, and by 13 times in BC+CT. The number of Streptococcus CFU also increased in all experimental groups: by 15.5 times in the BC without treatment group, by 4 times in BC+surgery, by 2.6 times in BC+PDT, by 4.5 times in BC+PDT+CT, and by 3.5 times in BC+CT. The number of Lactobacillus CFU significantly increased only in the BC+PDT group (by 2.5 times). The development of the microbiota in the tumor allows evaluating the impact of various types of therapy on the growth of opportunistic microorganisms. The results suggest that doxorubicin combined with PDT has the most potent effect on changes to the tumor microbiota.
我们对雌性Wistar大鼠的乳腺微生物群以及在给予N-甲基-N-亚硝基脲诱导乳腺癌(BC)后,经手术治疗、光动力疗法(PDT)和化疗(CT)后的乳腺癌相关微生物群进行了比较研究。采用选择性营养培养基和涂片指纹技术研究微生物群。在未处理的大鼠乳腺中发现了葡萄球菌、链球菌和乳酸杆菌。与未处理的动物相比,所有诱导性乳腺癌大鼠组中葡萄球菌CFU的平均数量在统计学上显著增加:未治疗的乳腺癌组增加了8倍,乳腺癌+手术组增加了15%,乳腺癌+PDT组增加了10倍,乳腺癌+PDT+CT组增加了4倍,乳腺癌+CT组增加了13倍。所有实验组中链球菌CFU的数量也增加了:未治疗的乳腺癌组增加了15.5倍,乳腺癌+手术组增加了4倍,乳腺癌+PDT组增加了2.6倍,乳腺癌+PDT+CT组增加了4.5倍,乳腺癌+CT组增加了3.5倍。乳酸杆菌CFU的数量仅在乳腺癌+PDT组显著增加(增加了2.5倍)。肿瘤中微生物群的发展有助于评估各种类型的治疗对机会性微生物生长的影响。结果表明,阿霉素联合PDT对肿瘤微生物群的变化具有最显著的影响。